Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PedvaxHIB

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Open-label, multicenter, randomized study (NCT00289913) evaluated immunogenicity, safety, and tolerability of Vaqta® (hepatitis A… Expand
2009
2009
  • MMWR. Morbidity and mortality weekly report
  • 2009
  • Corpus ID: 29717986
On December 13, 2007, certain lots of Haemophilus influenzae type b (Hib) vaccine marketed as PedvaxHIB (monovalent Hib vaccine… Expand
Review
2008
Review
2008
  • MMWR. Morbidity and mortality weekly report
  • 2008
  • Corpus ID: 20957145
In December 2007, Merck & Co., Inc. (West Point, Pennsylvania) announced a voluntary recall of certain lots of two Haemophilus… Expand
2007
2007
  • MMWR. Morbidity and mortality weekly report
  • 2007
  • Corpus ID: 23931909
On December 13, 2007, Merck & Co., Inc. (West Point, Pennsylvania) announced a voluntary recall of certain lots of two… Expand
2005
2005
PedvaxHIB is a pediatric vaccine that protects children from severe disease caused by the gram-negative bacterium Haemophilus… Expand
1997
1997
OBJECTIVE To determine the safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine… Expand
1991
1991
PedvaxHIB, a Haemophilus influenzae type b (Hib) conjugate vaccine composed of Hib capsular polysaccharide covalently bound to an… Expand
1990
1990
Although systemic infections caused by Haemophilus influenzae type b occur worldwide, detailed epidemiologic data are available… Expand